National and global treatment guidelines for COPD include Endobronchial Valves like Zephyr Valves with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) giving valves an ...

The Zephyr Valve Helps COPD/Emphysema Patients Breathe Easier Without the Risk of Major Surgery 1 REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx ...

NICE makes a 'strong' recommendation that patients with severe COPD be referred for evaluation for bronchoscopic lung volume reduction, including the Zephyr® Endobronchial Valve System. NICE has ...

Jul. 1—MORGANTOWN — A new treatment for emphysema is coming to West Virginia. The Zephyr Valve, a treatment classified a medical breakthrough by the Food and Drug Administration, will be ...

"It's just wonderful. I do have a new life now," Wells said. Not all COPD patients are candidates for the Zephyr valve. Lamb says there is a specific set of criteria they use to evaluate patients.

The Zephyr Valve has been shown in numerous published clinical trials to improve pulmonary function, exercise capacity, shortness of breath, and quality of life of patients with severe emphysema ...

Zephyr Valve treatment is included in emphysema treatment guidelines such as the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for Prevention, Diagnosis and ...

The study revealed that at 1 year, pulmonary function scores were improved by at least 15% in nearly half of participants (47.7%) treated with Zephyr valves vs. 16.8% of patients in the control group.

Gordon is using the Zephyr Valve System, which is the first Food and Drug Administration-approved, minimally invasive procedure of its kind that can help patients without resorting to major surgery.

Pulmonx received FDA approval in 2018 for its Zephyr Valve technology and launched commercial production shortly afterwards. To date, over 100,000 valves have been used to treat 25,000 patients.

REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx Corporation is announcing that over 20,000 patients have been treated worldwide with their Zephyr ...

The Zephyr Valve is commercially available in more than 25 countries, with over 100,000 valves used to treat more than 25,000 patients.